PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FABQ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $180,769
Award facts
- Contract value 100% obligated
- $180,768.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $180,768.90 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling Amerisourcebergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
The contract will be performed at Amerisourcebergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, the company competes on a full and open basis for procurement requirements and serves multiple government customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA Medical Supply Chain's strategic approach involves establishing multiple regional contracts with separate contractors under the planned Pharmaceutical Prime Vendor Global Program Generation V initiative, reflecting the government's commitment to maintaining a resilient and diversified pharmaceutical supply chain for military medical operations.
Quick answers
Who was awarded contract SPE2D826FABQ8?
SPE2D826FABQ8 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826FABQ8 worth?
The government has obligated $180,769 on SPE2D826FABQ8.
Is contract SPE2D826FABQ8 an order under another contract?
Yes. SPE2D826FABQ8 is a delivery order under SPE2DX22D0079, an indefinite delivery contract.
Was contract SPE2D826FABQ8 competed?
The extent of competition for SPE2D826FABQ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award